Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
12 Results for ''
Press Release
DNA origami-based vaccines toward safe and highly-effective precision cancer immunotherapy
March 15, 2024
Community
The Wyss Brain Targeting Program is expanding its “neural network”
January 25, 2024
Community
Neha Kapate on Backpacking her way into a New Frontier for Treating Incurable Diseases
June 23, 2023
Community
Reimagining treatment for brain diseases to improve the lives of patients and their families: Ana Raquel Santa Maria
May 11, 2023
Research Spotlights
Immunotherapy’s Next Act
March 15, 2023
Research Spotlights
Activating STING could make brain tumors more susceptible to treatment
July 14, 2022
Community
Nikolaos Dimitrakakis on Artificial Bone Marrow and Teamwork
June 17, 2022
Press Release
The Wyss Institute Welcomes Associate Faculty Member Natalie Artzi, Ph.D.
May 9, 2022
Community
Ana Raquel Santa Maria on Breaking Through the Blood-Brain Barrier to Treat Brain Disease
March 17, 2022
Translation News
Harvard’s Wyss Institute initiates industry partnership to facilitate brain-targeted drug delivery
June 10, 2021
Press Release
Machine-learning how to create better AAV gene delivery vehicles
February 11, 2021
Press Release
A new vision for AAV-delivered gene therapies
February 10, 2021
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
